skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 80,343  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Tumors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic value of molecular classification in stage IV endometrial cancer
Material Type:
Article
Add to My Research

Prognostic value of molecular classification in stage IV endometrial cancer

International journal of gynecological cancer, 2024-05, p.ijgc-2023-005058 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005058 ;PMID: 38658021

Digital Resources/Online E-Resources

2
Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study
Material Type:
Article
Add to My Research

Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.689-696 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005173 ;PMID: 38514100

Digital Resources/Online E-Resources

3
Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes
Material Type:
Article
Add to My Research

Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.722-729 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004955 ;PMID: 38460968

Digital Resources/Online E-Resources

4
Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer
Material Type:
Article
Add to My Research

Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.681-688 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005157 ;PMID: 38388180

Digital Resources/Online E-Resources

5
Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer
Material Type:
Article
Add to My Research

Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.659-666 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005165 ;PMID: 38378696

Digital Resources/Online E-Resources

6
Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass
Material Type:
Article
Add to My Research

Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.713-721 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005073 ;PMID: 38388177

Digital Resources/Online E-Resources

7
Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosis
Material Type:
Article
Add to My Research

Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosis

International journal of gynecological cancer, 2024-05, Vol.34 (5), p.705-712 [Peer Reviewed Journal]

IGCS and ESGO 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2024 IGCS and ESGO 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005108 ;PMID: 38508588

Digital Resources/Online E-Resources

8
Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial
Material Type:
Article
Add to My Research

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial

Current controlled trials in cardiovascular medicine, 2024-05, Vol.25 (1), p.301-301 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-024-08142-5 ;PMID: 38702828

Full text available

9
Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review
Material Type:
Article
Add to My Research

Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review

BMC women's health, 2024-05, Vol.24 (1), p.274-274 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1472-6874 ;EISSN: 1472-6874 ;DOI: 10.1186/s12905-024-03117-9 ;PMID: 38704534

Full text available

10
Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study
Material Type:
Article
Add to My Research

Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study

Ultrasound in obstetrics & gynecology, 2024-05, Vol.63 (5), p.683 [Peer Reviewed Journal]

2023 International Society of Ultrasound in Obstetrics and Gynecology. ;EISSN: 1469-0705 ;DOI: 10.1002/uog.27535 ;PMID: 37970762

Digital Resources/Online E-Resources

11
Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours
Material Type:
Article
Add to My Research

Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours

Basic & clinical pharmacology & toxicology, 2024-05, Vol.134 (5), p.629 [Peer Reviewed Journal]

2024 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd. ;EISSN: 1742-7843 ;DOI: 10.1111/bcpt.14002 ;PMID: 38501576

Digital Resources/Online E-Resources

12
Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings
Material Type:
Article
Add to My Research

Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings

Ultrasound in obstetrics & gynecology, 2024-05, Vol.63 (5), p.691 [Peer Reviewed Journal]

2023 International Society of Ultrasound in Obstetrics and Gynecology. ;EISSN: 1469-0705 ;DOI: 10.1002/uog.27454 ;PMID: 37592848

Digital Resources/Online E-Resources

13
Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis
Material Type:
Article
Add to My Research

Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis

International journal of gynecological cancer, 2024-04, p.ijgc-2023-005170 [Peer Reviewed Journal]

IGCS and ESGO 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. ;2024 IGCS and ESGO 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005170 ;PMID: 38688662

Digital Resources/Online E-Resources

14
UAE: 30.5kg tumour removed intact from ovary of 63-year-old Filipina driver
Material Type:
Newspaper Article
Add to My Research

UAE: 30.5kg tumour removed intact from ovary of 63-year-old Filipina driver

Gulf News, 2024-04-27

Al Nisr Publishing LLC 2022. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Digital Resources/Online E-Resources

15
Vaginal radical trachelectomy: is now the end of an era?
Material Type:
Article
Add to My Research

Vaginal radical trachelectomy: is now the end of an era?

International journal of gynecological cancer, 2024-04, p.ijgc-2024-005643 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2024-005643 ;PMID: 38677777

Digital Resources/Online E-Resources

16
SHEIKH SHAKHBOUT MEDICAL CITY TEAM SUCCESSFULLY REMOVES 30.5KG OVARIAN TUMOR
Material Type:
Newsletter Article
Add to My Research

SHEIKH SHAKHBOUT MEDICAL CITY TEAM SUCCESSFULLY REMOVES 30.5KG OVARIAN TUMOR

Mid-East.Info, 2024

Copyright © mid-east.info Provided by SyndiGate Media Inc. (Syndigate.info).

Digital Resources/Online E-Resources

17
Sheikh Shakhbout Medical City Team Successfully Removes 30.5kg Ovarian Tumor
Material Type:
Newsletter Article
Add to My Research

Sheikh Shakhbout Medical City Team Successfully Removes 30.5kg Ovarian Tumor

Mid-East.Info, 2024

Copyright © mid-east.info Provided by SyndiGate Media Inc. (Syndigate.info).

Digital Resources/Online E-Resources

18
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study
Material Type:
Article
Add to My Research

Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study

International journal of gynecological cancer, 2024-04, p.ijgc-2024-005331 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2024-005331 ;PMID: 38658019

Digital Resources/Online E-Resources

19
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis

International journal of gynecological cancer, 2024-04, p.ijgc-2024-005313 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2024-005313 ;PMID: 38658022

Digital Resources/Online E-Resources

20
Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas
Material Type:
Article
Add to My Research

Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas

International journal of gynecological cancer, 2024-04, p.ijgc-2023-005220 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005220 ;PMID: 38658016

Digital Resources/Online E-Resources

Results 1 - 20 of 80,343  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1969  (15)
  2. 1969 To 1988  (6,220)
  3. 1989 To 1999  (21,791)
  4. 2000 To 2011  (40,854)
  5. After 2011  (11,486)
  6. More options open sub menu

Language 

  1. English  (80,294)
  2. Japanese  (12,487)
  3. German  (89)
  4. Polish  (29)
  5. French  (19)
  6. Portuguese  (18)
  7. Turkish  (4)
  8. Norwegian  (3)
  9. Latin  (1)
  10. Chinese  (1)
  11. Spanish  (1)
  12. More options open sub menu

Searching Remote Databases, Please Wait